| Literature DB >> 35192511 |
Feng-Jiao Peng1, Paul Palazzi1, Sakina Mezzache2, Nasrine Bourokba3, Jeremie Soeur2, Brice M R Appenzeller1.
Abstract
Objective: Endogenous hormones regulate numerous physiological processes in humans. Some of them are routinely measured in blood, saliva and/or urine for the diagnosis of disorders. The analysis of fluids may, however, require multiple samples collected at different time points to avoid the high variability in the concentration of some hormones. In contrast, hair analysis has been proposed as an interesting alternative to reveal average hormone levels over a longer period. In this work, we developed and validated an analytical method for analyzing 36 endogenous steroid and thyroid hormones and one pineal hormone in human hair using ultra-performance liquid chromatography (UPLC)-tandem mass spectrometry (MS/MS).Entities:
Mesh:
Substances:
Year: 2022 PMID: 35192511 PMCID: PMC8942333 DOI: 10.1530/EJE-22-0081
Source DB: PubMed Journal: Eur J Endocrinol ISSN: 0804-4643 Impact factor: 6.664
Figure 1Biosynthesis pathways of hormones included in our method in the human body. Epitestosterone was not presented in this figure because it is not clear about its biological role and biosynthesis (28). AD, androstenedione; ALD, aldosterone; AN, androsterone; B, corticosterone; DHT, 5α-dihydrotestosterone; E, cortisone; E1, estrone; E2, 17β-estradiol; E3, estriol; F, cortisol; MEL, melatonin; P4, progesterone; P5, pregnenolone; rT3, 3,3’,5’-triiodo-L-thyronine; THE, tetrahydrocortisone; THF, tetrahydrocortisol; T2, 3,3’-diiodo-L-thyronine; T3, 3,3’,5-triiodo-L-thyronine; T4, 3,5,3’,5’-triiodo-L-thyronine; 2-MeOE1, 2-methoxyestrone; 2-MeOE2, 2-methoxyestradiol; 2-OHE1, 2-hydroxyestrone; 4-MeOE1, 4-methoxyestrone; 4-MeOE2, 4-methoxyestradiol; 4-OHE1, 4-hydroxyestrone; 11-deoxyF, 11-deoxycortisol; 11-DOC, 11-deoxycorticosterone; 16-ketoE2, 16-ketoestradiol; 16-OHE1, 16α-hydroxyestrone; 17OHP5, 17α-hydroxypregnenolone; 17OHP4, 17α-hydroxyprogesterone; 21-deoxyF, 21-deoxycortisol; αTHF, 5α-tetrahydrocortisol.
Concentrations (pg/mg) of hormones measured in hair samples collected from 196 healthy women.
| Hormone | DF (%) | Percentile | Range | LLoQ | LOD | ||||
|---|---|---|---|---|---|---|---|---|---|
| 2.5th | 25th | 50th | 75th | 97.5th | |||||
| E1 | 99 | 0.24 | 0.72 | 0.91 | 1.22 | 1.92 | nd–2.80 | 0.1 | 0.1 |
| E2 | 100 | 0.19 | 0.28 | 0.39 | 0.53 | 0.95 | 0.07–1.71 | 0.1 | 0.07 |
| E3 | 6 | nd | nd | nd | nd | 0.15 | nd–1.14 | 0.5 | 0.09 |
| 2-OHE1 | 37 | nd | nd | nd | 0.43 | 1.50 | nd–1.88 | 1 | 0.19 |
| 4-OHE1 | 2 | nd | nd | nd | nd | nd | nd–8.90 | 2 | 0.42 |
| 16-OHE1 | 34 | nd | nd | nd | 0.09 | 0.31 | nd–0.48 | 0.5 | 0.04 |
| 2-MeOE1 | 29 | nd | nd | nd | 0.15 | 0.87 | nd–1.37 | 0.5 | 0.1 |
| 4-MeOE1 | 0 | nd | nd | nd | nd | nd | nd | 1 | 1 |
| 2+4-MeOE2 | 99 | 0.38 | 1.16 | 2.15 | 3.58 | 9.66 | nd–13.3 | 0.5 | 0.15 |
| 16-ketoE2 | 0 | nd | nd | nd | nd | nd | nd | 1 | 1 |
| AD | 100 | 1.42 | 2.48 | 3.20 | 4.16 | 6.79 | 1.06–7.68 | 0.5 | 0.5 |
| T | 95 | nd | 0.32 | 0.42 | 0.58 | 0.96 | nd–1.10 | 0.5 | 0.15 |
| EpiT | 33 | nd | nd | nd | 0.40 | 0.89 | nd–1.82 | 0.5 | 0.22 |
| DHT | 62 | nd | nd | 0.77 | 1.62 | 6.24 | nd–7.88 | 0.5 | 0.36 |
| DHEA | 100 | 4.04 | 7.05 | 8.88 | 11.3 | 19.8 | 0.72–25.6 | 2 | 0.72 |
| DHEAS | 100 | 0.71 | 1.53 | 2.27 | 3.71 | 17.4 | 0.44–20.7 | 5 | 0.44 |
| AN | 0 | nd | nd | nd | nd | nd | nd | 10 | 10 |
| P5 | 58 | nd | nd | 8.01 | 15.2 | 34.4 | nd–44.2 | 10 | 4.45 |
| 17OHP5 | 0 | nd | nd | nd | nd | nd | nd | 10 | 10 |
| P4 | 100 | 1.59 | 6.20 | 8.99 | 11.8 | 22.5 | 0.51–35.0 | 0.2 | 0.2 |
| 17OHP4 | 100 | 1.07 | 1.73 | 2.34 | 2.89 | 4.92 | 0.60–6.37 | 0.2 | 0.2 |
| 11-DOC | 87 | nd | 0.14 | 0.19 | 0.23 | 0.38 | nd–0.69 | 0.2 | 0.08 |
| B | 54 | nd | nd | 0.61 | 1.01 | 2.17 | nd–2.42 | 2 | 0.43 |
| ALD | 7 | nd | nd | nd | nd | 0.24 | nd–0.47 | 2 | 0.09 |
| 11-deoxyF | 19 | nd | nd | nd | nd | 0.28 | nd–0.33 | 0.5 | 0.09 |
| 21-deoxyF | 0 | nd | nd | nd | nd | nd | nd | 1 | 1 |
| E | 100 | 5.08 | 7.64 | 9.83 | 13.6 | 37.3 | 4.19–47.6 | 0.5 | 0.5 |
| F | 100 | 1.91 | 2.61 | 3.37 | 4.65 | 11.0 | 1.20–13.2 | 0.5 | 0.5 |
| THE | 100 | 0.50 | 0.80 | 1.07 | 1.40 | 3.36 | 0.38–5.51 | 1 | 0.38 |
| THF | 100 | 1.22 | 2.19 | 2.88 | 4.29 | 10.8 | 1.09–14.2 | 2 | 1.09 |
| αTHF | 73 | nd | nd | 1.23 | 2.08 | 4.76 | nd–6.71 | 2 | 0.42 |
| T2 | 68 | nd | nd | 0.17 | 0.24 | 0.42 | nd–0.53 | 0.5 | 0.09 |
| T3 | 100 | 0.32 | 0.43 | 0.51 | 0.58 | 0.76 | 0.29–1.18 | 0.2 | 0.2 |
| rT3 | 93 | nd | 0.10 | 0.12 | 0.15 | 0.28 | nd-0.51 | 0.5 | 0.07 |
| T4 | 100 | 0.09 | 0.13 | 0.18 | 0.24 | 0.58 | 0.05–0.73 | 0.2 | 0.05 |
| MEL | 32 | nd | nd | nd | 0.09 | 2.89 | nd–7.80 | 0.2 | 0.02 |
AD, androstenedione; AN, androsterone; ALD, aldosterone; B, corticosterone; DF, detection frequency; DHT, 5α-dihydrotestosterone; E, cortisone; EpiT, epitestosterone; E1, estrone; E2, 17β-estradiol; E3, estriol; F, cortisol; LOD, limit of detection; LLoQ, limit of quantification; MEL, melatonin; nd, not detected; P4, progesterone; P5, pregnenolone; THE, tetrahydrocortisone; THF, tetrahydrocortisol; T2, 3,3’-diiodo-L-thyronine; T3, 3,3’,5-triiodo-L-thyronine; rT3, 3,3’,5’-triiodo-L-thyronine; T4, 3,5,3’,5’-triiodo-L-thyronine; 2-MeOE1, 2-methoxyestrone; 2-OHE1, 2-hydroxyestrone; 4-MeOE1, 4-methoxyestrone; 4-OHE1, 4-hydroxyestrone; 2+4-MeOE2, 2-methoxyestradiol and 4-methoxyestradiol; 11-deoxyF, 11-deoxycortisol; 11-DOC, 11-deoxycorticosterone; 16-ketoE2, 16-ketoestradiol; 16-OHE1, 16α-hydroxyestrone; 17OHP4, 17α-hydroxyprogesterone; 17OHP5, 17α-hydroxypregnenolone; 21-deoxyF, 21-deoxycortisol; αTHF, 5α-tetrahydrocortisol.
Figure 2Heatmap showing pairwise Kendall correlations between analyte concentrations in hair samples collected from 196 healthy women. The size of circle symbols represents the strength of correlations. A cross symbolizes that the correlation coefficient is one. Only analytes detected in more than 50% of samples are presented in the graph. AD, androstenedione; AND, androgens; B, corticosterone; COR, corticosteroids; DHT, 5α-dihydrotestosterone; E, cortisone; EST, estrogens; E1, estrone; E2, 17β-estradiol; F, cortisol; MeOE2, 2-methoxyestradiol and 4-methoxyestradiol; PRO, progestogens; P4, progesterone; P5, pregnenolone; rT3, 3,3’,5’-triiodo-L-thyronine; THE, tetrahydrocortisone; THF, tetrahydrocortisol; THY, thyroid hormones; T2, 3,3’-diiodo-L-thyronine; T3, 3,3’,5-triiodo-L-thyronine; T4, 3,5,3’,5’-triiodo-L-thyronine; 11DOC, 11-deoxycorticosterone; 17OHP4, 17α-hydroxyprogesterone; αTHF, 5α-tetrahydrocortisol. A full color version of this figure is available at https://doi.org/10.1530/EJE-22-0081.